Literature DB >> 24424452

Alternative models of comorbidity: a framework for the interpretation of epidemiological association studies.

Jochen Schmitt1, Stephan Weidinger2.   

Abstract

Relationships between chronic diseases have emerged as major clinical, public health and research issues. Consequently, clinical and epidemiological research on comorbidities of skin diseases is increasingly recognized as an important tool to understand their etiologies more fully and to capture their morbidities and burdens. In this issue, Flohr and colleagues report a cross-sectional analysis on the complex associations among atopic dermatitis, filaggrin loss-of-function mutations, skin barrier function, and food sensitization in exclusively breastfed infants. When interpreting this and other association studies, various alternative models of comorbidity should be considered as suggested by Neale and Kendler.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24424452     DOI: 10.1038/jid.2013.527

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  12 in total

Review 1.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care.

Authors:  Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-03       Impact factor: 6.053

Review 2.  Clinical practice. Atopic dermatitis.

Authors:  Hywel C Williams
Journal:  N Engl J Med       Date:  2005-06-02       Impact factor: 91.245

Review 3.  Atopic dermatitis and cancer risk.

Authors:  H Wang; T L Diepgen
Journal:  Br J Dermatol       Date:  2006-02       Impact factor: 9.302

4.  Complexity of the association between psoriasis and comorbidities.

Authors:  Tamar Nijsten; Marlies Wakkee
Journal:  J Invest Dermatol       Date:  2009-07       Impact factor: 8.551

Review 5.  How epidemiology has challenged 3 prevailing concepts about atopic dermatitis.

Authors:  Hywel Williams; Carsten Flohr
Journal:  J Allergy Clin Immunol       Date:  2006-06-09       Impact factor: 10.793

6.  Itches and scratches – is there a link between eczema, ADHD, sleep disruption and food hypersensitivity?

Authors:  M Romanos; A Buske-Kirschbaum; R Fölster-Holst; M Gerlach; S Weidinger; J Schmitt
Journal:  Allergy       Date:  2011-11       Impact factor: 13.146

Review 7.  Nonallergic comorbidities of atopic eczema: an overview of systematic reviews.

Authors:  S Deckert; C Kopkow; J Schmitt
Journal:  Allergy       Date:  2013-09-21       Impact factor: 13.146

8.  Models of comorbidity for multifactorial disorders.

Authors:  M C Neale; K S Kendler
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

Review 9.  How atopic is atopic dermatitis?

Authors:  Carsten Flohr; S G O Johansson; Carl-Fredrik Wahlgren; Hywel Williams
Journal:  J Allergy Clin Immunol       Date:  2004-07       Impact factor: 10.793

10.  Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease.

Authors:  Elke Rodríguez; Hansjörg Baurecht; Esther Herberich; Stefan Wagenpfeil; Sara J Brown; Heather J Cordell; Alan D Irvine; Stephan Weidinger
Journal:  J Allergy Clin Immunol       Date:  2009-06       Impact factor: 10.793

View more
  4 in total

1.  [Genome-associated studies in chronic inflammatory dermatoses].

Authors:  E Rodríguez; S Weidinger
Journal:  Internist (Berl)       Date:  2014-02       Impact factor: 0.743

Review 2.  [Nonallergic comorbidities of atopic dermatitis].

Authors:  S Deckert; J Schmitt
Journal:  Hautarzt       Date:  2015-02       Impact factor: 0.751

Review 3.  Revisiting the Roles of Filaggrin in Atopic Dermatitis.

Authors:  Verena Moosbrugger-Martinz; Corinne Leprince; Marie-Claire Méchin; Michel Simon; Stefan Blunder; Robert Gruber; Sandrine Dubrac
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

4.  Increased Risk of Cutaneous and Systemic Infections in Atopic Dermatitis-A Cohort Study.

Authors:  Sinéad M Langan; Katrina Abuabara; Sarah E Henrickson; Ole Hoffstad; David J Margolis
Journal:  J Invest Dermatol       Date:  2017-02-12       Impact factor: 8.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.